These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 36728287)
1. L-Fucose inhibits the progression of cholangiocarcinoma by causing microRNA-200b overexpression. Zhu B; Zheng J; Hong G; Bai T; Qian W; Liu J; Hou X Chin Med J (Engl); 2022 Dec; 135(24):2956-2967. PubMed ID: 36728287 [TBL] [Abstract][Full Text] [Related]
2. Role of AP-2α and MAPK7 in the regulation of autocrine TGF-β/miR-200b signals to maintain epithelial-mesenchymal transition in cholangiocarcinoma. Zhang D; Li H; Jiang X; Cao L; Wen Z; Yang X; Xue P J Hematol Oncol; 2017 Oct; 10(1):170. PubMed ID: 29084594 [TBL] [Abstract][Full Text] [Related]
3. Hepatocyte nuclear factor 6 inhibits the growth and metastasis of cholangiocarcinoma cells by regulating miR-122. Zhu H; Mi Y; Jiang X; Zhou X; Li R; Wei Z; Jiang H; Lu J; Sun X J Cancer Res Clin Oncol; 2016 May; 142(5):969-80. PubMed ID: 26825606 [TBL] [Abstract][Full Text] [Related]
4. Gankyrin promotes tumor growth and metastasis through activation of IL-6/STAT3 signaling in human cholangiocarcinoma. Zheng T; Hong X; Wang J; Pei T; Liang Y; Yin D; Song R; Song X; Lu Z; Qi S; Liu J; Sun B; Xie C; Pan S; Li Y; Luo X; Li S; Fang X; Bhatta N; Jiang H; Liu L Hepatology; 2014 Mar; 59(3):935-46. PubMed ID: 24037855 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-494-dependent WDHDI inhibition suppresses epithelial-mesenchymal transition, tumor growth and metastasis in cholangiocarcinoma. Liu B; Hu Y; Qin L; Peng XB; Huang YX Dig Liver Dis; 2019 Mar; 51(3):397-411. PubMed ID: 30314946 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-144 suppresses cholangiocarcinoma cell proliferation and invasion through targeting platelet activating factor acetylhydrolase isoform 1b. Yang R; Chen Y; Tang C; Li H; Wang B; Yan Q; Hu J; Zou S BMC Cancer; 2014 Dec; 14():917. PubMed ID: 25479763 [TBL] [Abstract][Full Text] [Related]
7. Akirin2 is modulated by miR-490-3p and facilitates angiogenesis in cholangiocarcinoma through the IL-6/STAT3/VEGFA signaling pathway. Leng K; Xu Y; Kang P; Qin W; Cai H; Wang H; Ji D; Jiang X; Li J; Li Z; Huang L; Zhong X; Sun X; Wang Z; Cui Y Cell Death Dis; 2019 Mar; 10(4):262. PubMed ID: 30886152 [TBL] [Abstract][Full Text] [Related]
8. Allicin Inhibits Proliferation and Invasion in Vitro and in Vivo via SHP-1-Mediated STAT3 Signaling in Cholangiocarcinoma. Chen H; Zhu B; Zhao L; Liu Y; Zhao F; Feng J; Jin Y; Sun J; Geng R; Wei Y Cell Physiol Biochem; 2018; 47(2):641-653. PubMed ID: 29794468 [TBL] [Abstract][Full Text] [Related]
9. FTY720 inhibits proliferation and epithelial-mesenchymal transition in cholangiocarcinoma by inactivating STAT3 signaling. Lu Z; Wang J; Zheng T; Liang Y; Yin D; Song R; Pei T; Pan S; Jiang H; Liu L BMC Cancer; 2014 Oct; 14():783. PubMed ID: 25344679 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-329-mediated PTTG1 downregulation inactivates the MAPK signaling pathway to suppress cell proliferation and tumor growth in cholangiocarcinoma. Hu ZG; Zheng CW; Su HZ; Zeng YL; Lin CJ; Guo ZY; Zhong FD; Yuan GD; He SQ J Cell Biochem; 2019 Jun; 120(6):9964-9978. PubMed ID: 30582202 [TBL] [Abstract][Full Text] [Related]
11. Luteolin arrests cell cycling, induces apoptosis and inhibits the JAK/STAT3 pathway in human cholangiocarcinoma cells. Aneknan P; Kukongviriyapan V; Prawan A; Kongpetch S; Sripa B; Senggunprai L Asian Pac J Cancer Prev; 2014; 15(12):5071-6. PubMed ID: 24998588 [TBL] [Abstract][Full Text] [Related]
12. Forced overexpression of FBP1 inhibits proliferation and metastasis in cholangiocarcinoma cells via Wnt/β-catenin pathway. Zhao W; Yang S; Chen J; Zhao J; Dong J Life Sci; 2018 Oct; 210():224-234. PubMed ID: 30193944 [TBL] [Abstract][Full Text] [Related]
13. Oncogenic Role of the NFATC2/NEDD4/FBP1 Axis in Cholangiocarcinoma. Zhao W; Zhao J; Li K; Hu Y; Yang D; Tan B; Shi J Lab Invest; 2023 Sep; 103(9):100193. PubMed ID: 37285922 [TBL] [Abstract][Full Text] [Related]
14. Cryptotanshinone induces cell cycle arrest and apoptosis through the JAK2/STAT3 and PI3K/Akt/NFκB pathways in cholangiocarcinoma cells. Ke F; Wang Z; Song X; Ma Q; Hu Y; Jiang L; Zhang Y; Liu Y; Zhang Y; Gong W Drug Des Devel Ther; 2017; 11():1753-1766. PubMed ID: 28670110 [TBL] [Abstract][Full Text] [Related]
15. Upregulated microRNA-194 impairs stemness of cholangiocarcinoma cells through the Rho pathway via inhibition of ECT2. Gao J; Dai C; Yu X; Yin XB; Zhou F J Cell Biochem; 2020 Oct; 121(10):4239-4250. PubMed ID: 31960990 [TBL] [Abstract][Full Text] [Related]
16. Direct targeting of SUZ12/ROCK2 by miR-200b/c inhibits cholangiocarcinoma tumourigenesis and metastasis. Peng F; Jiang J; Yu Y; Tian R; Guo X; Li X; Shen M; Xu M; Zhu F; Shi C; Hu J; Wang M; Qin R Br J Cancer; 2013 Dec; 109(12):3092-104. PubMed ID: 24169343 [TBL] [Abstract][Full Text] [Related]
17. LINC00844 suppresses tumor progression and predicts survival outcomes through inhibiting miR-19a-5p in cholangiocarcinoma. Zhang L; Jiang G; Lu J; Wang L Clin Transl Oncol; 2024 Feb; 26(2):414-423. PubMed ID: 37400667 [TBL] [Abstract][Full Text] [Related]
18. MiR-124 induces autophagy-related cell death in cholangiocarcinoma cells through direct targeting of the EZH2-STAT3 signaling axis. Ma J; Weng L; Wang Z; Jia Y; Liu B; Wu S; Cao Y; Sun X; Yin X; Shang M; Mao A Exp Cell Res; 2018 May; 366(2):103-113. PubMed ID: 29530475 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-551b-3p inhibits tumour growth of human cholangiocarcinoma by targeting Cyclin D1. Chang W; Wang Y; Li W; Shi L; Geng Z J Cell Mol Med; 2019 Aug; 23(8):4945-4954. PubMed ID: 31199052 [TBL] [Abstract][Full Text] [Related]
20. Enhanced expression of suppresser of cytokine signaling 3 inhibits the IL-6-induced epithelial-to-mesenchymal transition and cholangiocarcinoma cell metastasis. Zhou QX; Jiang XM; Wang ZD; Li CL; Cui YF Med Oncol; 2015 Apr; 32(4):105. PubMed ID: 25744243 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]